Beam Therapeutics BEAM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$94.32M— | —— | -$112.73M-9.2% | -$103.23M+4.7% | -$108.33M-19.9% | ||
| $5.61M-1.1% | $5.67M+1.9% | $5.56M+0.4% | $5.54M+0.2% | $5.53M+1.6% | ||
| $19.04M-6.9% | $20.45M-10.1% | $22.75M-6.6% | $24.37M-8.7% | $26.68M-11.7% | ||
| -$128.51M-54.3% | -$83.29M-2.2% | -$81.48M-6.6% | -$76.45M+26.4% | -$103.88M-36.0% | ||
| $2.23M-40.2% | $3.73M-25.5% | $5.01M+59.8% | $3.14M+2.3% | $3.07M+3.2% | ||
| $25.27M— | —— | —— | -$170.41M-36.2% | -$125.09M-199% | ||
| $93.89M— | —— | —— | —— | $0— | ||
| $96.61M+5,022% | $1.89M+12.6% | $1.68M+51.0% | $1.11M-99.8% | $473.38M+13,645% | ||
| -$6.64M-125% | $27M+291% | -$14.15M+94.2% | -$245.75M-201% | $244.41M— | ||
| -$130.75M-50.2% | -$87.02M-0.6% | -$86.49M-8.7% | -$79.59M+25.6% | -$106.95M-34.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beam Therapeutics generate?
- Beam Therapeutics (BEAM) generated -$369.7M in operating cash flow over the trailing twelve months.
- What is Beam Therapeutics's free cash flow?
- After $14.1M of capital expenditures, Beam Therapeutics's free cash flow was -$383.8M over the trailing twelve months, down 6.3% year over year.
- Where does Beam Therapeutics's cash flow data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
